Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessIFF Raises Full-Year Revenue Outlook Following Mixed Q3, Stock Rises 2 percent

IFF Raises Full-Year Revenue Outlook Following Mixed Q3, Stock Rises 2 percent

Add to Favorite
Added to Favorite


International Flavors & Fragrances (NYSE:IFF) shares rose around 2% pre-market today after the company reported mixed third-quarter results, with a slight earnings miss offset by a revenue beat that led the company to raise its full-year outlook. Adjusted earnings per share came in at $1.04, just below analyst estimates of $1.07, while revenue reached $2.93 billion, exceeding the expected $2.83 billion.
In the third quarter, IFF achieved growth across all its segments, with comparable currency-neutral sales increasing 9% year-over-year. The Health & Biosciences and Scent divisions saw double-digit growth, while Nourish and Pharma Solutions posted high single-digit increases. CEO Erik Fyrwald credited the performance to market recovery and a strong focus on meeting customer needs, which bolstered volumes across divisions.
Looking forward, the company raised its full-year 2024 revenue guidance to $11.3-$11.4 billion, up from a previous range of $11.1-$11.3 billion, and now anticipates volume growth of 5-6%, higher than the prior forecast of 3-5%.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Walmart deep discounts on Black Friday start early, web fans thrilled, CWEB reports

Walmart (WMT), the nation’s largest retailer, offers deep discounts...

Cerence Inc. (NASDAQ:CRNC) Faces Financial Challenges Amidst Automotive AI Competition

Cerence Inc. (NASDAQ:CRNC) reported an EPS of -$0.49, missing...